Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies
Sign Up to like & getrecommendations! Published in 2018 at "Leukemia"
DOI: 10.1038/s41375-018-0068-2
Abstract: Thus far, only 5–15% of AML patients aged ≥60 years are cured with chemotherapy. Identification of patients who are less (more) likely to respond to standard chemotherapy might enable early risk stratification toward alternative treatment… read more here.
Keywords: risk; aged years; patients novo; standard chemotherapy ... See more keywords
Arterial Access in Patients With De Novo Acute Coronary Syndrome Undergoing Coronary Angiography
Sign Up to like & getrecommendations! Published in 2017 at "Angiology"
DOI: 10.1177/0003319716652277
Abstract: Bleeding is a major limitation of antithrombotic therapy among invasively managed patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACSs). Randomized clinical trials have generally failed to favor either the femoral or the radial arterial approach… read more here.
Keywords: patients novo; arterial access; angiography; acute coronary ... See more keywords
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer
Sign Up to like & getrecommendations! Published in 2020 at "Cancers"
DOI: 10.3390/cancers12102855
Abstract: Simple Summary In randomized trials, both chemotherapy and androgen-receptor signaling inhibitors provided significant survival benefits in patients with metastatic prostate cancer (mPCa). However, it is largely unknown to what extent these therapeutic advances have impacted… read more here.
Keywords: patients novo; metastatic prostate; prostate cancer; survival patients ... See more keywords
A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation
Sign Up to like & getrecommendations! Published in 2022 at "Medicina"
DOI: 10.3390/medicina58121755
Abstract: Background and Objectives: After liver transplantation (LT), long-term immunosuppression (IS) is essential. IS is associated with de novo malignancies, and the incidence of colorectal cancer (CRC) is increased in LT patients. We assessed course of… read more here.
Keywords: reduction; patients novo; colorectal cancer; liver transplantation ... See more keywords